PHASE-I CLINICAL-TRIAL WITH CARBETIMER

被引：7

作者：

DODION, P

DEVALERIOLA, D

BODY, JJ

HOUA, M

NOEL, P

ABRAMS, J

CRESPEIGNE, N

WERY, F

KENIS, Y

机构：

[1] UNIV LIBRE BRUXELLES,INST JULES BORDET,CTR TUMEURS,SERV MED,ENDOCRINOL UNIT,B-1000 BRUSSELS,BELGIUM

[2] UNIV LIBRE BRUXELLES,INST JULES BORDET,CTR TUMEURS,LAB INVEST CLIN HJ TAGNON,B-1000 BRUSSELS,BELGIUM

[3] UNIV LIBRE BRUXELLES,HOP ST PIERRE,SERV NEUROL,B-1000 BRUSSELS,BELGIUM

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 02期

关键词：

D O I：

10.1016/0277-5379(89)90020-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：279 / &

共 14 条

[1]

[Anonymous], 1979, WHO HDB REPORTING RE

[2]

ARDALAN B, 1986, CANCER RES, V46, P5473

[3] CARBOXYIMAMIDATE, A LOW-MOLECULAR-WEIGHT POLY-ELECTROLYTE WITH ANTI-TUMOR PROPERTIES AND LOW TOXICITY [J].

FIELDS, JE ;

ASCULAI, SS ;

JOHNSON, JH ;

JOHNSON, RK .

JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (09) :1060-1064

[4]

FROMM M, 1986, P AM ASSOC CANC RES, V27, P206

[5]

GOTTSCHALK, 1970, SELECTED ABSTRACTS R, P36

[6]

GRUNBERG SM, 1987, P AM ASSOC CANC RES, V28, P224

[7] MITOZOLOMIDE (NSC-353451), A NEW ACTIVE-DRUG IN THE TREATMENT OF MALIGNANT-MELANOMA - PHASE-II TRIAL IN PATIENTS WITH ADVANCED DISEASE [J].

GUNDERSEN, S ;

AAMDAL, S ;

FODSTAD, O .

BRITISH JOURNAL OF CANCER, 1987, 55 (04) :433-435

[8]

HANAUSKE A, 1987, P AM SOC CLIN ONCOL, V6, P25

[9]

KISNER D, 1984, INVEST NEW DRUG, V2, P105

[10]

LUNA MC, 1987, P AM ASSOC CANC RES, V28, P433

← 1 2 →